Paul Uppal – 2014 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Paul Uppal on 2014-05-02.

To ask the Secretary of State for Health, what figures he holds on the life expectancy of men with metastatic castrate-resistant prostate cancer.

Jane Ellison

The Government’s Mandate to NHS England sets out an ambition to make England one of the most successful countries in Europe at preventing premature deaths from all cancers, including prostate cancer.

Cancer indicators in the NHS Outcomes Framework and the Public Health Outcomes Framework will help NHS England to assess progress in improving cancer survival and mortality for men with prostate cancer.

Data related to men with metastatic castration-resistant prostate cancer is not collected to permit the calculation of a reliable figure for average life expectancy.

However, Cancer Research UK has estimated that men with advanced, incurable prostate cancer treated in trials or under drug access schemes at the Royal Marsden Hospital survived on average 41 months, compared to between 13 and 16 months 10 years ago.